Lovesac，Avidity Biosciences，Veritone和其他大型股票在周四的市场前会议中走低

U.S. stock futures were higher this morning, with the Dow futures gaining around 0.2% on Thursday.

Shares of Lovesac Co (NASDAQ:LOVE) fell sharply in pre-market trading after the company posted results for its second quarter.

Lovesac reported quarterly losses of 45 cents per share which beat the analyst consensus estimate of losses of 71 cents per share. The company reported quarterly sales of $160.530 million which beat the analyst consensus estimate of $160.229 million.

Lovesac slashed its FY2026 GAAP EPS guidance from $0.80-$1.36 to $0.52-$1.05.

Lovesac shares tumbled 13% to $18.05 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

• Avidity Biosciences, Inc. (NASDAQ:RNA) fell 20.1% to $37.08 in pre-market trading after the company announced a $500 million offering of common stock.
• Veritone, Inc. (NASDAQ:VERI) declined 18.7% to $2.96 in pre-market trading as the company announced the pricing of $25 million public offering.
• Lesaka Technologies Inc (NASDAQ:LSAK) tumbled 15.8% to $3.98 in pre-market trading following fourth-quarter results.
• Murano Global Investments Plc (NASDAQ:MRNO) dipped 14.8% to $3.50 in pre-market trading after dipping 18% on Wednesday.
• QMMM Holdings Ltd (NASDAQ:QMMM) fell 13.2% to $95.01 in pre-market trading after dipping 47% on Wednesday.
• CI&T Inc. (NYSE:CINT) fell 9.8% to $4.53 in the pre-market trading after declining 3% on Wednesday.
• Enovix Corp (NASDAQ:ENVX) fell 7.1% to $8.50 in pre-market trading after the company announced a $300 million convertible notes offering.
• KT Corp (NYSE:KT) fell 4% to $18.95 in pre-market trading.

Now Read This:

• Adobe Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Photo via Shutterstock